Position in LLY
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$81,371,736
+$20,490,321 QoQ
Shares Held
67,842
+2.5% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
1.81%
of 13F equity value
Holder Rank
#423
of 4,605 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 14%
Shared 0%
None 86%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Apollon Wealth Management, LLC holds $214,410,726 across 14 Drug Manufacturers - General names. LLY ranks #1 (38.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
67,842 | $81,371,736 | |
| 2 | JNJ |
Johnson & Johnson
|
161,278 | $40,959,773 | |
| 3 | ABBV |
AbbVie Inc.
|
122,381 | $30,795,954 | |
| 4 | AZN |
Astrazeneca PLC
|
97,297 | $18,449,457 | |
| 5 | MRK |
Merck & Co., Inc.
|
96,041 | $12,341,268 | |
| 6 | AMGN |
Amgen Inc
|
23,363 | $8,460,209 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
104,485 | $6,020,425 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
38,585 | $4,874,828 |
All Filings in LLY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $81,371,736 | 67,842 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $60,881,415 | 66,192 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $46,616,398 | 43,377 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $32,569,418 | 42,686 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $29,924,597 | 38,388 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $28,177,571 | 34,117 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $15,170,572 | 19,651 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $12,606,926 | 14,230 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $12,036,121 | 13,294 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $10,055,133 | 12,925 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $7,973,762 | 13,679 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $4,871,769 | 9,070 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,048,100 | 10,764 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $2,795,782 | 8,141 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $2,699,533 | 7,379 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $2,351,401 | 7,272 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $2,182,392 | 6,731 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,801,267 | 6,290 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,338,562 | 4,846 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $576,700 | 2,496 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $249,258 | 1,086 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $364,299 | 1,950 | Shares | Sole | 2021-05-17 | |
| 2020-06-30 | $34,970 | 213 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||